SHTDF News and Press, Sinopharm Group Co. Ltd. From 04/03/22

RemeGen, a Yantai biotech with a deep portfolio of antibody and dual therapies, completed a $410 million IPO on the Shanghai Star Exchange. Nanjing Biosion out-licensed global rights (ex-China) to Pyxis Oncology for an immunotherapy aimed at solid tumor cancers in a $226 million agree...

Israel is set to become the first country in the world to administer a fourth COVID-19 vaccine, which would give "greater protection in the face of Omicron." The first eligible group to receive the vaccine will be people age 60 and older, as well as the immunocompromised and medical personnel...

Ocugen (OCGN +11.2%) has extended gains to reach the highest level since May ahead of a key meeting of an advisory panel of the World Health Organization (WHO) to decide on the emergency use listing for the COVID-19 vaccine it has partnered with Bharat Biotech. Last week, the WHO’...

A special report in Fortune Magazine October/November 2021 listed 53 Change The World (CTW) companies using plain old capitalism (including profits) to "address society's unmet needs." Many of the companies listed are battling to reverse the neglect exacerbated by Covid 19. Fortune pa...

Doubling down his opposition to an early rollout of COVID-19 boosters, the Director-General of World Health Organization (WHO) urges rich countries with an excess supply of COVID-19 vaccines to halt their plans for booster shots through the end of the year. The head of the global agency Dr. T...

The World Health Organization (WHO) says that COVID-19 is likely “here to stay with us” as the virus mutates like flu viruses making its elimination unlikely. Speaking at a press briefing, Dr. Mike Ryan, the executive director of the WHO’s Health Emergencies Program said:...

The World Health Organization (WHO) says it is monitoring a new coronavirus variant named “mu,” which, according to the agency, has the potential to escape the immunity gained from COVID-19 vaccines or natural infection. On August 30, WHO has added the “mu” variant...

The COVID-19 vaccine developed by Sinopharm Group (OTCPK:SHTDF) (OTCPK:SHTDY +2.0%) had a weaker antibody response against the Delta variant of the disease compared to the coronavirus variant first detected in Wuhan China, according to the first study of its kind on the vaccine. In the lab-ba...

mphillips007/iStock via Getty Images COVAX has called for all government authorities to recognize as "fully vaccinated" all people who have received COVID-19 vaccines authorized by the World Health Organization ((WHO)) as the Western countries open up their borders to inoculated travellers. T...

JP Yim/Getty Images Entertainment The Director-General of the World Health Organization ((WHO)), Dr. Tedros Adhanom Ghebreyesus on Thursday called for a global effort to vaccinate at least 10% of the population of every country by September against COVID-19. In a virtual address to India Glob...